An international probe reveals that several India-made chemotherapy drugs failed quality tests, risking lives across 100+ ...

Vani Pathuri holds a academic foundation in healthcare and business, beginning with a nursing degree from Owaisi College of ...

According to PETA, the inspection team found that Palamur Biosciences was using a wide range of animals for experimentation, ...

Digital payments provider Pine Labs Ltd. filed for an initial public offering in India, as the government’s digitization push ...

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a fast-growing market.

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

These machines boost productivity by increasing folding speed, reducing manual effort, and minimising errors, Varad Deshpande ...

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...

In a shocking revelation that could have grave implications for global cancer care, a recent investigation has uncovered that several chemotherapy drugs manufactured by Indian pharmaceutical companies ...

India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...

Chemotherapy drugs in over 100 countries fail quality tests, putting cancer patients at risk of ineffective treatments.